Jens-Ulrich Stegmann

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Top Venues

Advances in pharmacological and pharmaceutical sciences

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Christophe Dessart, Fernanda Tavares-da-Silva, Lionel Van Holle, Olivia Mahaux, Jens-Ulrich Stegmann
A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example. Advances in pharmacological and pharmaceutical sciences 2024 (2024)
Christophe Dessart, Fernanda Tavares-da-Silva, Lionel Van Holle, Olivia Mahaux, Jens-Ulrich Stegmann
A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example. Advances in pharmacological and pharmaceutical sciences 2024 (2024)
François Haguinet, Andrew Bate, Jens-Ulrich Stegmann
The futility of adverse drug event reporting systems for monitoring known safety issues: A case study of myocardial infarction with rofecoxib and other drugs. Pharmacoepidemiology and drug safety (2023)
Paola Pirrotta, Fernanda Tavares-da-Silva, Maribel Co, Nicolas Lecrenier, Caroline Hervé, Jens-Ulrich Stegmann
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. Drug safety 44 (12) (2021)
Viviane Jusot, Frider Chimimba, Nettie Dzabala, Olga Menang, Joy Cole, Gregory Gardiner, Opokua Ofori-Anyinam, Olakunle Oladehin, Cecilia Sambakunsi, Mphatso Kawaye, Jens-Ulrich Stegmann, Yolanda Guerra Mendoza
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi. Drug safety 43 (6) (2021)
Fernanda Tavares-da-Silva, Olivia Mahaux, Lionel Van Holle, François Haguinet, Harry Seifert, Jens-Ulrich Stegmann
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology. Drug safety 43 (12) (2021)